HOME         WEBSITE         SUBSCRIBE           E-GREETINGS   
                               

Monday, November 16, 2009

NAV of MFs gain in the week ended 13 November 2009

Returns of IT funds jumped 5.47% 

Mutual funds gained as major equity benchmark indices surged in the week ended 13 November 2009. Returns of IT funds, banking funds, Index Funds, ELSS Funds and Equity diversified funds advanced in the week ended 13 November 2009. All major categories have posted positive returns over the week.

Sensex gained 690.55 points or 4.27% to 16,848.83 and the S&P CNX Nifty rose 202.8 points or 4.22%, to 4998.95 in the week ended 13 November 2009. MFs' net selling of equities stood at Rs 165.80 crore while net buying of debt securities of Rs 3846.40 crore in the week ended 13 November 2009 (the data is available till 12 November 2009).


Equity diversified funds 

Equity-diversified funds' category average rose 3.22% underperforming the Sensex that gained 4.27% in the week ended 13 November 2009. Returns of HSBC Small Cap Fund grew the most that posted returns of 6.91%. JM Core 11 Fund - Series I, Tata Indo-Global Infrastructure Fund, and Sahara R.E.A.L Fund posted returns of 6.79%, 6.43%, and 6.22%, respectively. NAV of Sundaram BNP Paribas Entertain Opportunities and Religare AGILE Fund increased by 5.91% and 5.31%, respectively. No equity diversified fund fell in the week ended 13 November 2009.


ELSS Funds 

NAVs of the ELSS funds category grew 3.45% in the week ended 13 November 2009. NAV of SBI Tax Advantage Fund - Series I and JM Tax Gain Fund have increased by 6.22% and 5.06%, respectively. Returns of Religare AGILE Tax Fund grew 4.90%. IDFC Tax Saver (ELSS) scaled up by 4.43%. While no ELSS fund posted negative returns over the week.


Index Funds 

All 21 index funds posted positive returns over the week. NAVs of the index funds' category scaled up 4.11% underperforming both the Sensex and the Nifty in the week ended 13 November 2009. Among the Index funds, HDFC Index Fund-Sensex Plan has topped among others by posting returns of 4.30%. The returns of ICICI Pru Index Fund-Nifty Plan grew 4.27%. Returns of UTI-Master Index Fund and HDFC Index Fund-Sensex Plus Plan have increased by 4.25% and 4.24%, respectively.


Pharma Funds 

The average returns of pharma funds gained 1.69% underperforming the BSE Healthcare index that rose 2.19% for week ended 13 November 2009. All 4 pharma funds posted positive returns in the week. Returns of UTI-Pharma & Healthcare Fund and SBI Magnum SFU - Pharma Fund grew 1.80% and 1.71%, respectively. Reliance Pharma Fund posted positive returns of 1.67%.


FMCG Funds 

FMCG funds advanced by 1.72% outperforming the BSE FMCG Index that surged 1.70% over the week ended 13 November 2009. ICICI Pru FMCG Fund increased by 2.32%. Returns of SBI Magnum SFU - FMCG Fund gained 1.64%. Return of Franklin FMCG Fund rose 1.19%.


Mid Cap funds 

The Net asset value of the Mid Cap fund category scaled up 3.08% outperforming BSE MidCap that grew 2.63% while underperforming the CNX MidCap that rose 3.82%, respectively in the week ended 13 November 2009. Returns of DSP BR Micro-Cap Fund increased by 7.18%. NAV of SBI Magnum Midcap Fund rose 4.25%. HDFC Capital Builder and JM Mid Cap Fund posted returns of 3.80% and 3.66%, respectively. All 26 mid cap funds have posted positive returns over the week ended 13 November 2009.



Banking funds 

All seven banking funds posted positive returns over the week. The net asset value of the banking funds grew 4.27% returns underperforming BSE Bankex that increased by 5.28%. JM Financial Services Sector Fund topped by giving returns of 5.28%. UTI-Banking Sector Fund gained 4.91%. NAV Religare Banking Fund grew 4.53%. Returns of ICICI Pru Banking & Financial Services surged 4.05%.


IT funds 

NAV of six IT funds moved up by 5.47% underperforming the BSE Infotech index which gained 6.53% and the CNX IT that increased by 6.14%. SBI Magnum SFU - Infotech Fund increased by 7.21%. Franklin Infotech Fund and DSP BR Technology.com recorded positive returns of 5.88% and 5.41%, respectively. Returns of ICICI Pru Technology Fund went up by 4.48% over the week ended 13 November 2009.


Gold ETFs 

Gold prices have surged both the international and domestic markets in the week ended 13 November 2009. Thus, gold ETFs gained over the week. The price of gold has increased by nearly 0.66% and 0.57%, respectively in domestic (Mumbai) and international (London) markets in the week. The category average of GETFs increased by 0.42% in the week ended 13 November 2009. All five Gold ETFs posted positive returns over the week. Returns of UTI-Gold Exchange Traded Fund, Quantum Gold Fund, Gold BeES and Reliance Gold Exchange Traded Fund surged 0.42% each.



Arbitrage funds 

There was no change in category average of NAV of all arbitrage funds in the week ended 13 November 2009. JPMorgan India Alpha Fund and ICICI Pru Blended - Plan B posted returns of 0.25% and 0.04%, respectively. JM Arbitrage Advantage Fund and Kotak Equity Arbitrage Fund have recorded returns of 0.04% and 0.03%, respectively. Net asset value of Benchmark Derivative Fund, UTI-SPrEAD Fund and ICICI Pru Equity & Deriv -Income Optimis remained unchanged over the week ended 13 November 2009. NAV of 9 funds fell in the week. ICICI Pru Blended - Plan A and IDFC Arbitrage Plus - Plan A plunged 0.09% and 0.06%, respectively.


Balanced Funds 

Net asset value of the balanced funds moved up 1.68% in the week ended 13 November 2009 underperforming the Sensex. Among the balanced funds, Tata SIP Fund - Scheme II, Tata SIP Fund - Scheme I, Kotak Dynamic Asset Allocation enhanced by 6.24%, 6.16%, and 6.12%, respectively. HDFC Children's Gift Fund-Invt Plan grew 3.48%. Only one fund out of 77 balanced funds gave negative returns over week ended 13 November 2009. Returns of Kotak Wealth Builder - Series I fell 0.32%.


Gilt Funds 

NAVs of the gilt fund category scaled up 0.13% in the week ended 13 November 2009. This rise was mostly contributed due to marginal rise in price of Gsecs over the week, in which gilt funds invest heavily. Edelweiss Gilt Fund and LICMF G-Sec Fund - PF Plan posted positive returns of 1.28% and 0.46%, respectively. NAV of LICMF G-Sec Fund rose 0.46%. Returns of DWS Gilt Fund and Mirae Asset Gilt Fund - Invest increased by 0.34% and 0.30%, respectively. Returns of 2 out of 64 gilt funds declined over week ended 13 November 2009. ICICI Pru Gilt Fund - Invest - PF Option and DSP BR G-Sec Fund have tumbled 0.15% and 0.01%, respectively over the week


Income Funds 

The category average of income funds rose slightly 0.34% in the week ended 13 November 2009. NAV of ICICI Pru S.M.A.R.T. Fund - Sr.G - 36Mths gained 6.69% and ICICI Pru S.M.A.R.T. Fund - Sr.F - 36Mths increased by 3.21%. Returns of UTI-CCP Advantage Fund grew 3.19%. Returns of ICICI Pru S.M.A.R.T. Fund - Sr.H - 36Mths, ICICI Pru S.M.A.R.T. Fund - Sr.D - 24Mths increased by 2.91% and 1.32%, respectively. Returns of 7 out of 92 funds slipped over a week ended 13 November 2009. Birla Sun Life Income Fund and Birla Sun Life Income Fund 54EB fell 0.05% and 0.05%, respectively.



Weekly returns of various MF categories

Funds category
Absolute returns (%)*
            IT funds

5.47
         Banking funds

4.27
          Index Funds
4.11
ELSS Funds
3.45
Equity diversified funds
3.22
Mid Cap funds
3.08
FMCG Funds
1.72
Pharma Funds
1.69
Balanced Funds
1.68
Gold ETFs
0.42
Income Funds
0.34
Gilt Funds
0.13
Arbitrage funds
0.00

*As on week ended 13 November 2009


Posted by

Blog Archive

____________________________________________________________________________________________

Disclaimer - All investments in Mutual Funds and securities are subject to market risks and uncertainty of dividend distributions and the NAV of schemes may go up or down depending upon factors and forces affecting securities markets generally. The past performance of the schemes is not necessarily indicative of the future performance and may not necessarily provide a basis for comparison with other investments. Investors are advised to go through the respective offer documents before making any investment decisions. Prospective client(s) are advised to go through all comparable products in offer before taking any investment decisions. Mutual Funds and securities investments are subject to market risks and there is no assurance or guarantee that the objectives of the fund will be achieved. Information gathered & material used in this document is believed to be from reliable sources. Decisions based on the information provided on this newsletter/document are for your own account and risk.


In the preparation of the material contained in this document, Varun Vaid has used information that is publicly available, including information developed in-house. Some of the material used in the document may have been obtained from members/persons other than the Varun Vaid and which may have been made available to Varun Vaid. Information gathered & material used in this document is believed to be from reliable sources. Varun Vaid however does not warrant the accuracy, reasonableness and/or completeness of any information. For data reference to any third party in this material no such party will assume any liability for the same. Varun Vaid does not in any way through this material solicit any offer for purchase, sale or any financial transaction/commodities/products of any financial instrument dealt in this material. All recipients of this material should before dealing and or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice.


Varun Vaid, shall not liable for any loss, damage of any nature, including but not limited to direct, indirect, punitive, special, exemplary, consequential, as also any loss of profit in any way arising from the use of this material in any manner. The recipient alone shall be fully responsible/are liable for any decision taken on the basis of this material. All recipients of this material should before dealing and/or transacting in any of the products referred to in this material make their own investigation, seek appropriate professional advice. The investments discussed in this material may not be suitable for all investors. Any person subscribing to or investigating in any product/financial instruments should do soon the basis of and after verifying the terms attached to such product/financial instrument. Financial products and instruments are subject to market risks and yields may fluctuate depending on various factors affecting capital/debt markets. Please note that past performance of the financial products and instruments does not necessarily indicate the future prospects and performance there of. Such past performance may or may not be sustained in future. Varun Vaid, including persons involved in the preparation or issuance of this material may; (a) from time to time, have long or short positions in, and buy or sell the securities mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation in the financial instruments/products/commodities discussed here in or act as advisor or lender / borrower in respect of such securities/financial instruments/products/commodities or have other potential conflict of interest with respect to any recommendation and related information and opinions. The said person may have acted upon and/or in a manner contradictory with the information contained here. No part of this material may be duplicated in whole or in part in any form and or redistributed without the prior written consent of Varun Vaid. This material is strictly confidential to the recipient and should not be reproduced or disseminated to anyone else.


Varun Vaid also does not take any responsibility for the contents of the advertisements published. Readers are advised to verify the contents on their own before acting there upon.


Published Credits goes to following sources & all the mentioned sources as footer below the published material- Bloomberg, Valueresearch Online, Capital Market, Navindia, Franklin Templeton, Kitco, SBI AMC, LIC AMC, JM Financial AMC, HDFC AMC, The Hindu, Business Line, Personal FN, Economic Times, Reuters, Outlook Money, Business Standard, Times of India etc.